Q2056 commercial payer coverage policies | Backwork

Q2056 commercial payer coverage policies

19 commercial payer policies list Q2056. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.

Get free alerts for Q2056

Free account. Policy pages stay open to everyone.

Commercial payer policies listing Q2056

19 policies from 16 payers

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.

AmeriHealth

AmeriHealth policies listing Q2056, with the code’s status in each
Policy	Effective	Status of Q2056
Chimeric Antigen Receptor T-cell (CAR-T) Therapy: Carvykti and AbecmaPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-190	Not recorded	Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug.
Chimeric Antigen Receptor Therapy (CART): Carvykti & AbecmaPayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-50	Not recorded	Covered with conditionsInferred from policy title

Independence Blue Cross

Independence Blue Cross policies listing Q2056, with the code’s status in each
Policy	Effective	Status of Q2056
Chimeric Antigen Receptor T-cell (CAR-T) Therapy: Carvykti and AbecmaPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-190	Not recorded	Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug.
Chimeric Antigen Receptor Therapy (CART): Carvykti & AbecmaPayerPolicy · IBX-COMMERCIAL-08-02-50	Not recorded	Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug.

Point32Health

Point32Health policies listing Q2056, with the code’s status in each
Policy	Effective	Status of Q2056
Carvykti (ciltacabtagene autoleucel)PayerPolicy · POINT32HEALTH-MDMNG-12551	Not recorded	Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug.
Carvykti (ciltacabtagene autoleucel)PayerPolicy · POINT32HEALTH-MDMNG-12561	Not recorded	Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug.

Arkansas Blue Cross and Blue Shield

Arkansas Blue Cross and Blue Shield policies listing Q2056, with the code’s status in each
Policy	Effective	Status of Q2056
Ciltacabtagene Autoleucel (e.g., Carvykti)PayerPolicy · ARKBLUE-CILTACABTAGENE-AUTOLEUCEL-E-G-CARVYKTI	Not recorded	Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug.

Blue Cross Blue Shield of Michigan and Blue Care Network

Blue Cross Blue Shield of Michigan and Blue Care Network policies listing Q2056, with the code’s status in each
Policy	Effective	Status of Q2056
CARVYKTI (CILTACABTAGENE AUTOLEUCEL)PayerPolicy · BCBSM-2160720	Not recorded	Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug.

BlueCross BlueShield of Tennessee

BlueCross BlueShield of Tennessee policies listing Q2056, with the code’s status in each
Policy	Effective	Status of Q2056
Ciltacabtagene Autoleucel (Carvykti)PayerPolicy · BCBSTN-7c36b06d5c	Jun 1, 2022	Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug.

Health Net Oregon

Health Net Oregon policies listing Q2056, with the code’s status in each
Policy	Effective	Status of Q2056
Ciltacabtagene Autoleucel (Carvykti); CP.PHAR.533PayerPolicy · HEALTHNET_OR-CP-PHAR-533	Not recorded	Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug.

Humana

Humana policies listing Q2056, with the code’s status in each
Policy	Effective	Status of Q2056
Chimeric Antigen Receptor (CAR) T-cell TherapyPayerPolicy · HUMANA-CHIMERIC-ANTIGEN-RECEPTOR-CAR-T-CELL-THERAPY-MA	Aug 3, 2026	Covered

Mass General Brigham Health Plan

Mass General Brigham Health Plan policies listing Q2056, with the code’s status in each
Policy	Effective	Status of Q2056
CarvyktiPayerPolicy · MGBHP-CARVYKTI-728B5A01A1	Not recorded	Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug.

MetroPlusHealth

MetroPlusHealth policies listing Q2056, with the code’s status in each
Policy	Effective	Status of Q2056
UM-MP346 Carvykti (ciltacabtagene autoleucel)PayerPolicy · METROPLUS-UM-MP346	Not recorded	Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug.

Moda Health

Moda Health policies listing Q2056, with the code’s status in each
Policy	Effective	Status of Q2056
Carvykti (ciltacabtagene autoleucel)PayerPolicy · MODA-CARVYKTI-D1C37637A8	Not recorded	Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug.

Oscar Health

Oscar Health policies listing Q2056, with the code’s status in each
Policy	Effective	Status of Q2056
Carvykti (ciltacabtagene autoleucel; cilta-cel) (CG067, Ver. 7)PayerPolicy · OSCAR-CG067-MEDICAL	Not recorded	Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug.